Get started
Author

Tomáš Vaňásek

Observed names: T Vanasek, T Vanásek, T Vańásek, T Vaňásek, T. Vanasek, T. Vaňásek, Thomas Vanasek, Tomas Vanasek, Tomas Vaňásek, Tomás Vanásek, Tomás̆ Van̆ásek, Tomáš Vanásek, Vanasek, T.
ORCID: 0009-0002-4276-2321
Observed ORCID: 0009-0002-4276-2321
OpenAlex ID: A5035521266
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017 · Jean-Frederic Colombel, Remo Panaccione, et al. · The Lancet · 938
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
2022 · Bruce E Sands, Peter M Irving, et al. · The Lancet · 316
PDF
Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
2020 · Ryan C. Ungaro, Clara Yzet, et al. · Gastroenterology · 244
PDF
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
2017 · Séverine Vermeire, William J Sandborn, et al. · The Lancet · 191
Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 152
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
2013 · Satish Keshav, Tomáš Vaňásek, et al. · PLoS ONE · 136
PDF
Value of Doppler Sonography in Revealing Transjugular Intrahepatic Portosystemic Shunt Malfunction
2000 · Jan Z̆iz̆ka, Pavel Eliás̆, et al. · American Journal of Roentgenology · 83
Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis
2016 · Radan Keil, Martin Wasserbauer, et al. · Scandinavian Journal of Gastroenterology · 63
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
2021 · Walter Reinisch, William J Sandborn, et al. · Journal of Crohn s and Colitis · 41
PDF
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
2019 · Remo Panaccione, Jean-Frederic Colombel, et al. · Gut · 36
PDF
Influence of the Secondary Deployment of Expanded Polytetrafluoroethylene–covered Stent Grafts on Maintenance of Transjugular Intrahepatic Portosystemic Shunt Patency
2010 · Vaclav Jirkovsky, Tomas Fejfar, et al. · Journal of Vascular and Interventional Radiology · 31
A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool
2020 · Subrata Ghosh, Tom Sensky, et al. · Journal of Crohn s and Colitis · 29
PDF
901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study
2015 · Walter Reinisch, William Sandborn, et al. · Gastroenterology · 26
Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding
2011 · Pavel Drastich, Jan Lata, et al. · Annals of Hepatology · 26
PDF
Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat to Target Approach Versus Clinical Symptoms: Data from Calm
2017 · Jean Frederic Colombel, Remo Panaccione, et al. · Gastroenterology · 19
Management of Acute Variceal Bleeding
2003 · Jan Lata, Petr Hulek, et al. · Digestive Diseases · 19
Spontaneous bacterial peritonitis in the Czech Republic
2003 · Jan Lata, Tomas Fejfar, et al. · European Journal of Gastroenterology & Hepatology · 18
OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM
2019 · C Yzet, R Ungaro, et al. · Journal of Crohn s and Colitis · 14
PDF
Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region.
2002 · Josef Dvorák, Jirí Petera, et al. · PubMed · 13
[Probiotics in acute pancreatitis--a randomised, placebo-controlled, double-blind study].
2010 · J Lata, J Juránková, et al. · PubMed · 9
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study
2024 · Silvio Danese, Gionata Fiorino, et al. · Journal of Clinical Medicine · 8
PDF
[MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
2006 · T Fejfar, V Safka, et al. · PubMed · 8
Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: fourth, updated edition
2019 · Martin Bortlík, Dana Ďuricová, et al. · Gastroenterologie a hepatologie · 7
Guidelines for the administration of biological therapy in patients with Crohn´s disease and ulcerative colitis: third updated edition
2016 · Martin Bortlík, Dana Ďuricová, et al. · Gastroenterologie a hepatologie · 7
[Budd-Chiari syndrome and TIPS--twelve years' experience].
2005 · V Safka, P Hůlek, et al. · PubMed · 7
Works count: 83
Citation count: 2,509
H-index: 17
I10-index: 19
Year
Topic
Type